Given the importance of the functionality of the CD8+ T-cells for effective immune responses to tumors and viral infections (35–37) this finding is very encouraging for the future exploration of PCI-mediated vaccination in therapeutic vaccination settings. This evidence concerns the gene CD8A and viral infectious disease.